CLINICAL AND LABORATORY STUDIES OF 1,25‐DIHYDROXYCHOLECALCIFEROL IN MYELOFIBROSIS
- 1 February 1987
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 65 (2) , 252-254
- https://doi.org/10.1111/j.1365-2141.1987.00252.x-i1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- THE USEFULNESS OF 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2 vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1986
- Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disordersBritish Journal of Haematology, 1984
- CLINICAL EVIDENCE FOR 1,25-HYDROXYCHOLECALCIFEROL ACTION IN MYELOFIBROSISThe Lancet, 1984
- A ROLE FOR 1,25-DIHYDROXYVITAMIN D3 IN CONTROL OF BONE-MARROW COLLAGEN DEPOSITION?The Lancet, 1984
- The growth of large megakaryocyte colonies from human bone marrowJournal of Cellular Physiology, 1982